BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4394473)

  • 1. Hemodynamic effects of phenoxybenzamine in anesthetized dogs.
    Fowler NO; Holmes JC; Gaffney TE; Privitera PJ; Grupp G
    J Clin Invest; 1970 Nov; 49(11):2036-50. PubMed ID: 4394473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating beta adrenergic stimulator during elevated cerebrospinal fluid pressure.
    Brashear RE; Ross JC
    Arch Intern Med; 1971 Apr; 127(4):748-53. PubMed ID: 4396673
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of the autonomic nervous system in mediating the response to naloxone in canine hemorrhagic shock.
    Lechner RB; Gurll NJ; Reynolds DG
    Circ Shock; 1985; 16(3):279-95. PubMed ID: 2865016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: The release of adrenaline and noradrenaline by the adrenal glands of cats and dogs in reflexes arising from the carotid chemoreceptors and baroreceptors.
    Critchley JA; Ungar A; Welburn PJ
    J Physiol; 1973 Oct; 234(2):111P-112P. PubMed ID: 4767037
    [No Abstract]   [Full Text] [Related]  

  • 8. The cardiovascular activity of 2-amino-5-(3,4-dichlorophenoxymethyl)-2-oxazoline (APMO).
    Abdallah AH; White HD
    Toxicol Appl Pharmacol; 1973 Dec; 26(4):513-22. PubMed ID: 4149198
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of chloralose in catecholamine-depleted or receptor-blocked dogs.
    Charney AN; Bass BG; Buckley NM
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):397-405. PubMed ID: 5473799
    [No Abstract]   [Full Text] [Related]  

  • 10. The coronary blood flow effects caused by the carotid sinus reflex and the exogenous catecholamine.
    Ito K; Koshino M; Sasaki T; Kuriyama G; Hayashi A
    Jpn Heart J; 1973 Nov; 14(6):531-8. PubMed ID: 4151714
    [No Abstract]   [Full Text] [Related]  

  • 11. Central hemodynamic effects of adrenaline with special reference to beta 2-adrenergic influence on heart rate and cardiac afterload in anesthetized cats.
    Gustafsson D; Björkman JA
    Acta Physiol Scand; 1984 Dec; 122(4):553-64. PubMed ID: 6151780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new anorexic agent, WY-5244: cardiovascular actions and influence on sympathomimetic amines.
    Baum T; Gluckman MI
    J Pharmacol Exp Ther; 1967 Jul; 157(1):32-41. PubMed ID: 4382099
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of carotid sinus reflex, cardiac distention and catecholamines in the vagal escape mechanism.
    Peiss CN; Priola DV; Spurgeon HA
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):347-58. PubMed ID: 4155281
    [No Abstract]   [Full Text] [Related]  

  • 14. Baroreflex mechanisms buffering alpha-adrenergic agonists in conscious dogs.
    Fujii AM; Vatner SF
    Am J Physiol; 1987 Oct; 253(4 Pt 2):H728-36. PubMed ID: 2889369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dibenzyline upon catecholamine levels in arterial tissue and plasma and upon peripheral blood flow measurements in the anesthetized dog.
    Clauss RH; Terry EN; Messina E; Redish W
    J Cardiovasc Surg (Torino); 1969; 10(5):394-9. PubMed ID: 5365329
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of arterial baroreceptors in mediating the cardiovascular response to a cardiac glycoside in conscious dogs.
    McRitchie RJ; Vatner SF
    Circ Res; 1976 Apr; 38(4):321-6. PubMed ID: 1260975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
    Setler PE; Pendleton RG; Finlay E
    J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
    Côté P; Polumbo RA; Harrison DC
    Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of beta-adrenergic agonists on splanchnic vascular volume and cardiac output.
    Chang PI; Rutlen DL
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1499-507. PubMed ID: 1683172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.
    Higashio T; Tsuji Y; Nakao K; Sakaguchi S; Tanaka M
    Arzneimittelforschung; 1988 Mar; 38(3):350-8. PubMed ID: 3382459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.